Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Statement of the Problem:
KCNQ2 mutations have been found in patients with familial benign neonatal seizures, myokymia
or early onset epileptic encephalopathy. The diagnosis of neonatal seizures could be difficult
and challenging in some cases. KCNQ2 encodes the potassium channel subunit Kv7.2 and its
mutations have been shown to cause benign familial neonatal seizures (BFNS) with a favourable
prognosis but are also associated with neonatal onset seizures and poor outcomes, such as early
onset epileptic encephalopathy (EOEE).
Patients: We present a summary of our experience with neonatal seizures associated with
KCNQ2 mutations. In all cases a full diagnostic evaluation including MRI was performed before
the DNA analysis. The first patient has a positive family history, early onset tonic neonatal
seizures, clinical signs of encephalopathy. The following mutation was identified: c638G>A,p.
Arg213Gin, exon 4, KCNQ2, seizure free on carbamazepine treatment The second patient
presented with early tonic seizures, tonic eye deviations, burst-suppression EEG pattern, MRI
�hypoplasia of corpus callosum, clinical evidence of severe encephalopathy, KCNQ2 mutation
associated with EIEE was identified: G18416>A,pGly281Arg, exon 6. The third clinical case
is a term baby presented with early seizures �generalized tonic and facial myoclonic, KCNQ2
mutation c.637C>TpArg213T, exon 4, successful treatment with carbamazepine, but severe
developmental delay. Our fourth patient was with a positive family history, early tonic and
clonic seizures, no evidence of encephalopathy, KCNQ2 mutation � partial deletion of exon
17, known as a cause of benign familial neonatal seizures. This infant is seizure free and the
neurodevelopment is completely normal.
Conclusion:
KCNQ2 mutations could be associated with variable clinical presentation, the genetic testing
should be performed in all neonates with unknown seizure cause after complete diagnostic
evaluation.
Biography
Ralitza Gueorgieva has her expertise as neonatologist in NICU, University Pediatric Hospital in Sofia. The main scientific interests are focused on the fields of neonatal intensive care and neonatal neurology. The team of the department has a great experience managing neonates born with perinatal asphyxia and hypoxic-ischemic encephalopathy, premature infants with different perinatal brain lesions. Another important issue in our clinical and scientific work is the treatment and follow up of infants with neonatal seizures.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, ºÚÁÏÍø Journals